Pharma Product Commercialization: Standardized Team Processes Help Save Complex Dru...( CHAPEL HILL N.C. Jan. 31 /- The n...),Health

CHAPEL HILL, N.C., Jan. 31 /PRNewswire/ -- The new product development process is exceedingly complex. It spans many years, involves multitudes of people, and consumes hundreds of millions of dollars in capital resources. Not surprisingly, one pharmaceutical marketing executive noted: "This process is so complex that no single person in the organization actually knows how all the parts work."

For this reason, benchmark partners emphasize the importance of standardizing the new-product development process while implementing strong cross-functional launch teams. This team's role of shaping the compound into a successful product is just as important as the biological attributes of the compound. With standardization, individuals and teams can better understand where and how to introduce market insights into the long-spanning commercialization process.

The report, "Managing Cross-Functional Teams for Pharmaceutical Product Commercialization Excellence," delivers proven practices that best-in-class firms use to enable and manage effective cross-functional teams, such as empowering launch teams to make key decisions and team members following well- established, standardized processes.

Download a complimentary study summary at http://www3.best-in-class.com/rr906.htm.

Learn from industry leaders, including Amgen, AstraZeneca, Bayer, Eli Lilly GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, and Wyeth. Executives in pharma and biotech companies can use this research to build and manage strong launch teams that can excel across functions, units and regions.

High-performing systems find many places and methods to introduce standardization into commercialization activities, for example:
-- Conduct strategy meetings to forge consensus between Strategic

Marketing, Decision Analytics, R&D, Regulatory, Finance

-- Model markets for
'/>"/>